Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Centessa Pharmaceuticals plc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −2 vs. Q1 2022
- Shares held
- 71.8M
- −2.73M (−3.7%) vs. Q1 2022
- Total value
- $350.3M
- −$318.6M (−47.6%) vs. Q1 2022
- New holders
- 7
- 14 more added
- Sold out
- 9
- 9 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $97.2M | 40.37% | 00.0% | Unchanged |
| Index Venture Life Associates VI Ltd | 9,961,789 | $48.5M | 100.00% | 00.0% | Unchanged |
| General Atlantic LLC | 9,681,818 | $47.1M | 0.62% | 00.0% | Unchanged |
| BVF Inc | 6,894,345 | $33.6M | 1.62% | +5,138,800+292.7% | Added |
| Vida Ventures Advisors, LLC | 3,931,818 | $19.1M | 16.18% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 3,428,520 | $16.7M | 0.01% | −2,189,299−39.0% | Reduced |
| OUP Management Co., LLC | 2,937,615 | $14.3M | 19.69% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 2,927,273 | $14.3M | 1.11% | +437,379+17.6% | Added |
| Price T Rowe Associates Inc | 2,461,130 | $12.0M | 0.00% | −67,453−2.7% | Reduced |
| Samsara BioCapital, LLC | 1,693,736 | $8.25M | 2.21% | −190,360−10.1% | Reduced |
| Woodline Partners LP | 1,314,652 | $6.40M | 0.10% | +432,019+48.9% | Added |
| Boxer Capital, LLC | 1,251,137 | $6.09M | 0.39% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,127,273 | $5.49M | 0.03% | 00.0% | Unchanged |
| Franklin Resources Inc | 832,932 | $4.06M | 0.00% | +216,029+35.0% | Added |
| Kynam Capital Management, LP | 757,848 | $3.69M | 0.95% | +88,748+13.3% | Added |
| American Century Companies Inc | 517,577 | $2.52M | 0.00% | +342+0.1% | Added |
| Logos Global Management LP | 399,801 | $1.95M | 0.36% | −54,744−12.0% | Reduced |
| BlackRock Inc. | 301,915 | $1.47M | 0.00% | +25,397+9.2% | Added |
| EcoR1 Capital, LLC | 292,320 | $1.42M | 0.05% | −162,225−35.7% | Reduced |
| Citadel Advisors LLC | 290,583 | $1.42M | 0.00% | −13,843−4.5% | Reduced |
| JPMorgan Chase & Co | 178,414 | $869.0K | 0.00% | +173,698+3,683.2% | Added |
| Mirae Asset Global Investments Co., Ltd. | 57,342 | $703.0K | 0.00% | +57,342 | New |
| Point72 Asset Management, L.P. | 133,600 | $651.0K | 0.00% | −773,400−85.3% | Reduced |
| Ensign Peak Advisors, Inc | 123,071 | $599.0K | 0.00% | −193,530−61.1% | Reduced |
| TD Asset Management Inc | 82,055 | $400.0K | 0.00% | +48,803+146.8% | Added |
| Manufacturers Life Insurance Company, The | 57,421 | $286.5K | 0.00% | 00.0% | Unchanged |
| Oasis Management Co Ltd. | 57,700 | $281.0K | 0.05% | +57,700 | New |
| Alps Advisors Inc | 55,785 | $272.0K | 0.00% | +55,785 | New |
| Morgan Stanley | 40,264 | $196.0K | 0.00% | +18,652+86.3% | Added |
| Jane Street Group, LLC | 39,335 | $192.0K | 0.00% | +39,335 | New |
| Goldman Sachs Group Inc | 16,543 | $81.0K | 0.00% | +16,543 | New |
| FMR LLC | 10,300 | $50.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 6,046 | $29.0K | 0.00% | −38,131−86.3% | Reduced |
| Advisor Group Holdings, Inc. | 1,950 | $8.00K | 0.00% | +935+92.1% | Added |
| Tower Research Capital LLC (TRC) | 1,477 | $7.00K | 0.00% | +232+18.6% | Added |
| Citigroup Inc | 1,225 | $6.00K | 0.00% | +314+34.5% | Added |
| Adirondack Trust Co | 925 | $5.00K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 568 | $3.00K | 0.00% | +568 | New |
| Global Retirement Partners, LLC | 350 | $2.00K | 0.00% | 00.0% | Unchanged |
| Crewe Advisors LLC | 220 | $1.00K | 0.00% | +220 | New |
| State of Wyoming | 96 | $0 | 0.00% | +23+31.5% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −3,577,094−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −1,053,142−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −727,273−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −411,361−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −65,282−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −13,969−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −11,400−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Golden State Equity Partners | – | – | – | – | Not filed |